Clinical Trial Update: Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study [Phase 2]

View source ↗

Summary

Phase 2 extension study assessing safety and tolerability of creatine in premanifest Huntington's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED